Axelle Dupont

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Florence Ader, Nathan Peiffer‐Smadja, Julien Poissy et al. · Clinical Microbiology and Infection · 2021 · 102 citations · Full text

Clinical Infectious Disease, Open-label Randomized, Antiviral Drug Development +6

Surgery and risk of Guillain-Barré syndrome

Jérémie Rudant, Axelle Dupont, Yann Mikaeloff et al. · Neurology · 2018 · 71 citations

Long‐Term Outcome and Prognostic Factors of Complications in Thromboangiitis Obliterans (Buerger's Disease): A Multicenter Study of 224 Patients

Alexandre Le Joncour, Simon Soudet, Axelle Dupont et al. · Journal of the American Heart Association · 2018 · 65 citations · Full text

Prognostic Factors, Logistic Analysis, Thrombosis +18

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Anne‐Claire Mamez, Axelle Dupont, Didier Blaise et al. · Journal of Hematology & Oncology · 2020 · 52 citations · Full text

Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients

Cyril Mousseaux, Axelle Dupont, Cédric Rafat et al. · Annals of Intensive Care · 2019 · 50 citations · Full text